Virios Therapeutics Llc News

VIRIDelisted Stock  USD 3.95  0.00  0.00%   
Under 55% of Virios Therapeutics' investor base is interested to short. The analysis of current outlook of investing in Virios Therapeutics Llc suggests that many traders are impartial regarding Virios Therapeutics' prospects. Virios Therapeutics' investing sentiment shows overall attitude of investors towards Virios Therapeutics Llc.
  
over six months ago at investing.com         
Virios Therapeutics seeks global patent for antiviral combo
Investing News at Macroaxis
over six months ago at investing.com         
Acquisition by Keefer David R of 4709 shares of Virios Therapeutics at 0.357 subject to Rule 16b-3
Investing News at Macroaxis
over six months ago at news.google.com         
Short Interest in Virios Therapeutics, Inc. Decreases By 36.8 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Q1 2024 Earnings Estimate for Virios Therapeutics, Inc. Issued By HC Wainwright - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Virios Therapeutics, Inc. to Post FY2028 Earnings of 0.06 Per Share, HC Wainwright Forecasts - Defen...
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Virios Therapeutics, Inc. Short Interest Update
news
over six months ago at seekingalpha.com         
Virios Therapeutics reports Q4 results
seekingalpha News
over six months ago at globenewswire.com         
Virios Therapeutics AnnouncesFourth Quarter and Full Year 2023 Financial Results
Macroaxis News: globenewswire.com
over six months ago at investing.com         
Virios Therapeutics plans shareholder meeting on stock split
Investing News at Macroaxis
over six months ago at investing.com         
Acquisition by Burch Richard Alan of 2917 shares of Virios Therapeutics subject to Rule 16b-3
Investing News at Macroaxis
over six months ago at investing.com         
Virios Therapeutics announces salary cuts for employees and board
Investing News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Gregory Duncan of 138835 shares of Virios Therapeutics at 0.357 subject to Rule 16b-3
Macroaxis News
over six months ago at finance.yahoo.com         
VIRI Moving IMC-2 into Phase 2 Program in Long COVID
Yahoo News
over six months ago at news.google.com         
10 Best Dividend Growth Stocks to Buy and Hold in 2024 - Insider Monkey
Google News at Macroaxis
over six months ago at news.google.com         
U.S. shares higher at close of trade Dow Jones Industrial Average up 0.36 percent By Investing.com -...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Virios Therapeutics that are available to investors today. That information is available publicly through Virios media outlets and privately through word of mouth or via Virios internal channels. However, regardless of the origin, that massive amount of Virios data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Virios Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Virios Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Virios Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Virios Therapeutics alpha.

Virios Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
08/01/2024
2
VIRI Stock Earnings Virios Therapeutics Beats EPS for Q2 2024
08/08/2024
3
VIRI Enrollment Complete in Phase 2a Long COVID Trial Results Expected in October 2024
08/13/2024
4
Virios Therapeutics stock hits 52-week low at 0.15 - Investing.com
10/01/2024
5
Virios Therapeutics Soars Over 33 percent on Merger Announcement
10/08/2024
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in Virios Stock

If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings